Junyan Lu
- Molecular Biology top 10%
- Epigenetics and DNA Methylation 9
- Cancer-related gene regulation 6
- PI3K/AKT/mTOR signaling in cancer 5
- Glycosylation and Glycoproteins Research 4
- Sphingolipid Metabolism and Signaling 4
- Genetics top 10%
- Chronic Lymphocytic Leukemia Research 17
- Oncology top 10%
- Cell Biology top 10%
-
- Lymphoma Diagnosis and Treatment 6
-
- Immunodeficiency and Autoimmune Disorders 5
- Co-authors
- Cheng LuoHualiang JiangXiangqian KongZhongjie LiangSisheng OuyangGuoliang XuChuan HeXingyu Lu
- Partner nations
- ChinaGermanySwitzerland
In The Last Decade
Junyan Lu
55 papers receiving 1.8k citations
Hit Papers
Peers
Comparison fields: 5 of 115
- Molecular Biology 1.2k
- Genetics 141
- Computational Theory and Mathematics 176
- Oncology 276
- Cell Biology 162
Countries citing papers authored by Junyan Lu
This map shows the geographic impact of Junyan Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Junyan Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Junyan Lu more than expected).
Fields of papers citing papers by Junyan Lu
This network shows the impact of papers produced by Junyan Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Junyan Lu. The network helps show where Junyan Lu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Junyan Lu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 2 | |
| 3 | 2024 | 2 | |
| 4 | 2023 | 7 | |
| 5 | 2023 | 18 | |
| 6 | 2022 | 2 | |
| 7 | 2022 | 19 | |
| 8 | 2022 | 10 | |
| 9 | 2022 | 1 | |
| 10 | 2021 | 11 | |
| 11 | 2020 | 6 | |
| 12 | 2020 | 17 | |
| 13 | Reduction of Liver Metastasis Stiffness Improves Response to Bevacizumab in Metastatic Colorectal Cancerbreakdown → | 2020 | 236 |
| 14 | 2019 | 21 | |
| 15 | 2017 | 36 | |
| 16 | 2017 | 36 | |
| 17 | 2015 | 38 | |
| 18 | 2015 | 5 | |
| 19 | 2014 | 166 | |
| 20 | 2013 | 13 |
About Junyan Lu
Junyan Lu is a scholar working on Genetics, Molecular Biology, Immunology, Pathology and Forensic Medicine and Molecular Medicine, having authored 57 papers that have together received 1.9k indexed citations. Recurring topics across this work include Chronic Lymphocytic Leukemia Research (17 papers), Epigenetics and DNA Methylation (9 papers), Cancer-related gene regulation (6 papers), Lymphoma Diagnosis and Treatment (6 papers), PI3K/AKT/mTOR signaling in cancer (5 papers), Immunodeficiency and Autoimmune Disorders (5 papers), Glycosylation and Glycoproteins Research (4 papers) and Sphingolipid Metabolism and Signaling (4 papers). The work is most often cited by research in Molecular Biology (1.2k citations), Genetics (141 citations), Computational Theory and Mathematics (176 citations), Oncology (276 citations) and Cell Biology (162 citations). Junyan Lu has collaborated with scholars based in China, Germany and Switzerland. Frequent co-authors include Cheng Luo, Hualiang Jiang, Xiangqian Kong, Zhongjie Liang, Sisheng Ouyang, Guoliang Xu, Chuan He, Xingyu Lu, Liang Zhang and Haihua Liang. Their work appears in journals such as Blood, PLoS ONE, Leukemia, Blood Advances and Haematologica.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.